Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype

Background: LIV1 is a transmembrane protein that may become a new therapeutic target through the development of antibody–drug conjugates (ADCs). Few studies are available regarding the assessment of LIV1 expression in clinical breast cancer (BC) samples. Methods: We analyzed LIV1 mRNA expression in...

Descripción completa

Detalles Bibliográficos
Autores principales: de Nonneville, Alexandre, Finetti, Pascal, Boudin, Laurys, Denicolaï, Emilie, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058875/
https://www.ncbi.nlm.nih.gov/pubmed/36986799
http://dx.doi.org/10.3390/pharmaceutics15030938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058875/
https://www.ncbi.nlm.nih.gov/pubmed/36986799
http://dx.doi.org/10.3390/pharmaceutics15030938

Ejemplares similares